Cologuard Plus es una prueba de detección de ADN no invasiva, basada en muestras de heces, diseñada para detectar tanto el cáncer colorrectal como lesiones precancerosas avanzadas. En el estudio pivotal BLUE-C, Cologuard Plus ha demostrado una sensibilidad del 95% para el cáncer...
Hence then, the article about cologuard plus de abbott recibe la marca ce para la deteccion del cancer colorrectal en europa was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Cologuard Plus® de Abbott recibe la marca CE para la detección del cáncer colorrectal en Europa )
Also on site :
- Tourist Killed in Freak Accident During Tour of Frank Lloyd Wright Home, Which Attracts Over 100,000 Visitors a Year
- 1980 Quarterfish Hit, With an Iconic Saxaphone Solo, Named One of the Greatest Power Ballads of All Time
- PSG vs Barcelona: Kick-Off Time, Expected Lineups and How to Watch the Champions League Clash